Technical Analysis for ZFGN - Zafgen, Inc.

Grade Last Price % Change Price Change
grade F 2.66 0.76% 0.02
ZFGN closed up 0.76 percent on Friday, May 24, 2019, on 89 percent of normal volume. It ran into resistance at its 50 day moving average. The price action carved out a bearish shooting star candlestick pattern. That may indicate a downside reversal. Look for price to trade beneath the low of the shooting star for confirmation.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Up
See historical ZFGN trend table...

Date Alert Name Type % Chg
50 DMA Resistance Bearish 0.00%
Shooting Star Candlestick Bearish 0.00%
Lizard Bearish Bearish Day Trade Setup 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Pocket Pivot Bullish Swing Setup 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
Doji - Bearish? Reversal 0.00%
BB Squeeze + Upper Band Touch Range Contraction 0.00%
Upper Bollinger Band Touch Strength 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.76%

Older signals for ZFGN ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Zafgen, Inc. is a biopharmaceutical company. The Company is engaged in improving the health and well-being of patients affected by obesity. Beloranib, the Company’s product candidate, is a twice-weekly subcutaneous injection being developed for the treatment of multiple indications, including obesity and hyperphagia, or insatiable life-threatening hunger and hunger-related behaviors, in Prader-Willi Syndrome (PWS), craniopharyngioma-associated obesity, and severe obesity in the general population. PWS is a rare and complex genetic disorder characterized by physiologic, cognitive and behavioral symptoms, including hyperphagia and obesity. Craniopharyngioma is a rare form of benign brain tumor that occurs near the optic nerve, pituitary gland and hypothalamus. Approximately 30% to 50% of cases of craniopharyngioma are diagnosed in childhood and adolescence.
Medicine Biopharmaceutical Organ Systems Obesity Neuroendocrinology Prader Willi Syndrome
Is ZFGN a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 12.355
52 Week Low 2.33
Average Volume 224,762
200-Day Moving Average 6.2601
50-Day Moving Average 2.6914
20-Day Moving Average 2.5995
10-Day Moving Average 2.584
Average True Range 0.1348
ADX 17.83
+DI 26.532
-DI 15.5057
Chandelier Exit (Long, 3 ATRs ) 2.4225
Chandelier Exit (Short, 3 ATRs ) 2.7854
Upper Bollinger Band 2.715
Lower Bollinger Band 2.484
Percent B (%b) 0.76
BandWidth 8.886324
MACD Line -0.0467
MACD Signal Line -0.0756
MACD Histogram 0.0289
Fundamentals Value
Market Cap 73.1 Million
Num Shares 27.5 Million
EPS -1.88
Price-to-Earnings (P/E) Ratio -1.41
Price-to-Sales 0.00
Price-to-Book 0.95
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.96
Resistance 3 (R3) 2.98 2.90 2.91
Resistance 2 (R2) 2.90 2.83 2.89 2.89
Resistance 1 (R1) 2.78 2.78 2.84 2.76 2.87
Pivot Point 2.71 2.71 2.74 2.69 2.71
Support 1 (S1) 2.58 2.63 2.65 2.56 2.45
Support 2 (S2) 2.51 2.58 2.50 2.43
Support 3 (S3) 2.39 2.51 2.41
Support 4 (S4) 2.36